Skip to main content
. 2012 Oct;167(3):627–640. doi: 10.1111/j.1476-5381.2012.02028.x

Figure 3.

Figure 3

Effects of URB597 on FAAH and NAPE PLD protein expression in the ipsilateral spinal cord (see Figure 1 legend for further details of drug treatments). A (i, iii): Neither acute, nor repeated, URB597 altered FAAH protein levels. A (ii, iv), B (i, ii): Acute and repeated administration of URB597 reduced NAPE-PLD protein levels by approximately two-thirds, compared with the corresponding vehicle treated groups. AVS (Acute vehicle + saline), AUS (Acute URB597 + saline), AVC (Acute Vehicle + carrageenan), AUC (Acute URB597 + carrageenan), RVS (Repeated vehicle + saline), RUS (Repeated URB597 + saline), RVC (Repeated Vehicle + carrageenan), RUC (Repeated URB597 + carrageenan), n= 3, per each treatment group, performed in duplicate. Statistical analysis with one-way anova with a Bonferroni's post test, *P < 0.05, **P < 0.01, ***P < 0.001.